blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3886863

EP3886863 - ANTIVIRAL PRODRUGS AND NANOFORMULATIONS THEREOF [Right-click to bookmark this link]
StatusRequest for examination was made
Status updated on  03.09.2021
Database last updated on 11.09.2024
FormerThe international publication has been made
Status updated on  06.06.2020
Most recent event   Tooltip31.10.2023New entry: Renewal fee paid 
Applicant(s)For all designated states
Board of Regents of the University of Nebraska
Varner Hall
3835 Holdrege Street
Lincoln, NE 68583 / US
[2021/40]
Inventor(s)01 / GENDELMAN, Howard, E.
125 S. 127th Plaza
Omaha, NE 68154 / US
02 / EDAGWA, Benson
310 N. 40th Street, Apt. 9
Omaha, NE 68131 / US
 [2021/40]
Representative(s)HGF
HGF Limited
1 City Walk
Leeds LS11 9DX / GB
[N/P]
Former [2021/40]HGF
1 City Walk
Leeds LS11 9DX / GB
Application number, filing date19891191.927.11.2019
[2021/40]
WO2019US63498
Priority number, dateUS201862772852P29.11.2018         Original published format: US 201862772852 P
[2021/40]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2020112931
Date:04.06.2020
Language:EN
[2020/23]
Type: A1 Application with search report 
No.:EP3886863
Date:06.10.2021
Language:EN
The application published by WIPO in one of the EPO official languages on 04.06.2020 takes the place of the publication of the European patent application.
[2021/40]
Search report(s)International search report - published on:US04.06.2020
(Supplementary) European search report - dispatched on:EP01.12.2022
ClassificationIPC:A61K31/675, C07D413/14
[2021/40]
CPC:
C07D519/00 (EP); A61K47/55 (EP,US); A61K9/146 (EP,US);
A61P31/18 (EP,US); C07D215/56 (EP); C07D413/14 (EP);
C07D498/14 (EP); C07D498/18 (EP); A61K9/145 (EP) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2021/40]
TitleGerman:ANTIVIRALE PRODRUGS UND NANOFORMULIERUNGEN DAVON[2021/40]
English:ANTIVIRAL PRODRUGS AND NANOFORMULATIONS THEREOF[2021/40]
French:PROMÉDICAMENTS ANTIVIRAUX ET NANOFORMULATIONS DE CEUX-CI[2021/40]
Entry into regional phase22.06.2021National basic fee paid 
22.06.2021Search fee paid 
22.06.2021Designation fee(s) paid 
22.06.2021Examination fee paid 
Examination procedure29.05.2021Observations by third parties
22.06.2021Examination requested  [2021/40]
29.06.2023Amendment by applicant (claims and/or description)
Fees paidRenewal fee
22.06.2021Renewal fee patent year 03
28.11.2022Renewal fee patent year 04
31.10.2023Renewal fee patent year 05
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[Y]WO2017223280  (VIIV HEALTHCARE CO [US], et al) [Y] 1-15 * schemes;; example -; claim - *;
 [Y]  - ZHOU TIAN ET AL, "Creation of a nanoformulated cabotegravir prodrug with improved antiretroviral profiles", BIOMATERIALS, ELSEVIER, AMSTERDAM, NL, (20171015), vol. 151, doi:10.1016/J.BIOMATERIALS.2017.10.023, ISSN 0142-9612, pages 53 - 65, XP085235415 [Y] 1-15 * abstract *

DOI:   http://dx.doi.org/10.1016/j.biomaterials.2017.10.023
 [Y]  - BRADY SILLMAN ET AL, "Creation of a long-acting nanoformulated dolutegravir", NATURE COMMUNICATIONS, (20180206), vol. 9, no. 1, doi:10.1038/s41467-018-02885-x, XP055666371 [Y] 1-15 * abstract *

DOI:   http://dx.doi.org/10.1038/s41467-018-02885-x
 [Y]  - NAMANJA HILDA A. ET AL, "Toward Eradicating HIV Reservoirs in the Brain: Inhibiting P-Glycoprotein at the Blood-Brain Barrier with Prodrug Abacavir Dimers", JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, (20110909), vol. 134, no. 6, doi:10.1021/ja206867t, ISSN 0002-7863, pages 2976 - 2980, XP055925238 [Y] 1-15 * abstract *

DOI:   http://dx.doi.org/10.1021/ja206867t
International search[A]US6124327  (SILVERMAN KEITH C [US], et al) [A] 1-3, 4/1-3, 5/4/1-3, 8-11* ; column 1, lines 61-67; column 2, lines 1-60; column 7, lines 10-13 *;
 [A]US2011183940  (JOHNS BRIAN ALVIN [US], et al) [A] 1-3, 4/1-3, 5/4/1-3, 8-11 * ; paragraph [0004] *;
 [A]US2015297587  (GELBARD HARRIS A [US], et al) [A] 1-3, 4/1-3, 5/4/1-3, 8-11 * ; paragraphs *;
 [A]US2016184332  (RENNER JUERGEN [DE]) [A] 1-3, 4/1-3, 5/4/1-3, 8-11 * ; abstract *;
 [A]US2018051043  (YU TAO [US], et al) [A] 1-3, 4/1-3, 5/4/1-3, 8-11 * ; paragraph [0025] *;
 [A]  - ZHOU, T et al., "Creation of a nanoformulated cabotegravir prodrug with improved antiretroviral profiles", Biomaterials, (20180100), vol. 151, doi:10.1016/j.biomaterials.2017.10.023, pages 53 - 65, XP085235415 [A] 1-3, 4/1-3, 5/4/1-3, 8-11 * ; abstract *

DOI:   http://dx.doi.org/10.1016/j.biomaterials.2017.10.023
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.